Saurabh Jain
Saurabh Jain is the executive chairman of Opyl, an ASX-listed clinical trial results analysis company that utilizes artificial intelligence to predict outcomes in medical trials. Under his leadership, Opyl has recently ventured into cryptocurrency investment, purchasing Bitcoin as part of a treasury strategy, which he views as an opportunity for better returns compared to traditional cash holdings.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Saurabh Jain is the executive chairman of Opyl, which has invested in bitcoin.
7